Why the study?
Cudrania tricuspidata root extract reportedly inhibits platelet aggregation, prompting investigation of its active flavonoid Sanggenon N.
Does Sanggenon N inhibit collagen-induced platelet aggregation in human platelets?
Does Sanggenon N inhibit collagen-induced platelet aggregation in human platelets?
Sanggenon N demonstrates potent in vitro antiplatelet effects by inhibiting collagen-induced aggregation via the Ca2+ signaling pathway, suggesting potential as a therapeutic candidate for thrombosis.
Hypothesis-generating for Sanggenon N as antiplatelet agent; requires in vivo validation before clinical consideration.
Cudrania tricuspidata (C. tricuspidata), a medicinal plant widely employed throughout Asia in ethnomedicine, has various bioactive properties, including antidiabetic, antiobesity, antitumor, and anti-inflammatory activities. In addition, the C. tricuspidata root extract reportedly inhibits platelet aggregation. Therefore, we focused on the active substances present in the C. tricuspidata extract. Sanggenon N (SN) is a flavonoid found in the root bark of C. tricuspidata. In the present study, we examined the inhibitory effects of SN on platelet aggregation, phosphoproteins, thromboxane A 2 generation, and integrin IIb3 activity. SN inhibited collagen-induced human platelet aggregation in a dosedependent manner without cytotoxicity. Furthermore, SN suppressed Ca 2+ mobilization and influx through associated signaling molecules, such as inositol 1, 4, 5-triphosphate receptor I (Ser 1756 ), and extracellular signal-regulated kinase. In addition, SN inhibited thromboxane A 2 generation and associated signaling molecules, including cytosolic phospholipase A 2 and mitogen-activated protein kinase p38. Finally, SN could inhibit integrin (IIb/ 3 ) activity by regulating vasodilator-stimulated phosphoprotein and Akt. Collectively, SN possesses potent antiplatelet effects and is a potential therapeutic drug candidate to prevent platelet-related thrombosis and cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Hyuk-Woo Kwon (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: